Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding study of CHF 4226 (carmoterol) MDI in COPD
2006-000531-10Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of carmoterol in chronic obstructive pulmonary disease (COPD) (4 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Change in trough FEV1 on Day 14. Started Aug 2006; status: completed.
02
Drugs
carmoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2006-000531-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000531-10.